Europe Healthcare CRO Services Market By Service Type (Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services) By End User (Pharmaceutical companies, Medical Device Companies and Academic Institutes) By Therapeutic Area (Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas) By Country, Industry Analysis and Forecast, 2019 - 2025
The Europe Healthcare CRO Market would witness market growth of 5.9% CAGR during the forecast period (2019-2025).
Healthcare project management helps companies improve and function more efficiently in several ways. Perhaps the greatest advantage of hospital project management is that it can minimize the possibility of litigation that prevails for every organization in healthcare. Step by step establishing processes removes as many adverse results as possible. Managing a project aligns money with the operation. In other words, it guarantees at various points of a project that you have the money for your efforts. You'll know, for example, if you have the budget to start a project. As and when additional costs occur, it is important to have a mechanism in place to update the budget and re-prioritize as appropriate.
Growing investments by several governmental organizations in research & development activities and rising demand for successful therapies for chronic disease management are likely to raise the market sales of CRO services in North America over the forecast period. Due to increasing healthcare awareness, rising demand for technologically advanced and therapeutically successful products and huge spending on healthcare services in the region, the region is likely to continue its dominance.
Europe was found to be the second dominant region on the global contract research organization (CRO) services market in 2018 due to the strong emphasis on research and development activities of the region's leading pharmaceutical, biotechnology and medtech firms.
Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.
Scope of the Study
Market Segmentation:
Asia Pacific Healthcare CRO Market Segmentation
By Service Type
Healthcare project management helps companies improve and function more efficiently in several ways. Perhaps the greatest advantage of hospital project management is that it can minimize the possibility of litigation that prevails for every organization in healthcare. Step by step establishing processes removes as many adverse results as possible. Managing a project aligns money with the operation. In other words, it guarantees at various points of a project that you have the money for your efforts. You'll know, for example, if you have the budget to start a project. As and when additional costs occur, it is important to have a mechanism in place to update the budget and re-prioritize as appropriate.
Growing investments by several governmental organizations in research & development activities and rising demand for successful therapies for chronic disease management are likely to raise the market sales of CRO services in North America over the forecast period. Due to increasing healthcare awareness, rising demand for technologically advanced and therapeutically successful products and huge spending on healthcare services in the region, the region is likely to continue its dominance.
Europe was found to be the second dominant region on the global contract research organization (CRO) services market in 2018 due to the strong emphasis on research and development activities of the region's leading pharmaceutical, biotechnology and medtech firms.
Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.
Scope of the Study
Market Segmentation:
Asia Pacific Healthcare CRO Market Segmentation
By Service Type
- Clinical Research Services
- Early Phase Development
- Laboratory Services and
- Consulting Services
- Pharmaceutical companies
- Medical Device Companies and
- Academic Institutes
- Oncology
- CNS Disorder
- Cardiovascular Disease
- Diabetes
- Metabolic Diseases
- Infectious Diseases and
- Other therapeutic areas
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- IQVIA Holdings, Inc.
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Pharmaceutical Product Development, Inc.
- Parexel International Corporation (Pamplona Capital Management)
- Charles River Laboratories International, Inc.
- ICON PLC
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Syneos Health, Inc.
- Pharmaron Beijing Co., Ltd.
- GVK Biosciences Private Limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Healthcare CRO Services Market, by Service Type
1.4.2 Europe Healthcare CRO Services Market, by End User
1.4.3 Europe Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Europe Healthcare CRO Services Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Aug – 2020, Mar) Leading Players
CHAPTER 4. EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE
4.1 Europe Clinical Research Services Market by Country
4.2 Europe Early Phase Development Market by Country
4.3 Europe Laboratory Services Market by Country
4.4 Europe Consulting Services Market by Country
CHAPTER 5. EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER
5.1 Europe Pharmaceutical Sector Market by Country
5.2 Europe Medical Device Sector Market by Country
5.3 Europe Academic Institutes Market by Country
CHAPTER 6. EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS
6.1 Europe Oncology Market by Country
6.2 Europe CNS Disorder Market by Country
6.3 Europe Cardiovascular Disease Market by Country
6.4 Europe Diabetes Market by Country
6.5 Europe Metabolic Diseases Market by Country
6.6 Europe Infectious Diseases Market by Country
6.7 Europe Other therapeutic areas Market by Country
CHAPTER 7. EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY
7.1 Germany Healthcare CRO Services Market
7.1.1 Germany Healthcare CRO Services Market by Service Type
7.1.2 Germany Healthcare CRO Services Market by End User
7.1.3 Germany Healthcare CRO Services Market by Therapeutic Areas
7.2 UK Healthcare CRO Services Market
7.2.1 UK Healthcare CRO Services Market by Service Type
7.2.2 UK Healthcare CRO Services Market by End User
7.2.3 UK Healthcare CRO Services Market by Therapeutic Areas
7.3 France Healthcare CRO Services Market
7.3.1 France Healthcare CRO Services Market by Service Type
7.3.2 France Healthcare CRO Services Market by End User
7.3.3 France Healthcare CRO Services Market by Therapeutic Areas
7.4 Russia Healthcare CRO Services Market
7.4.1 Russia Healthcare CRO Services Market by Service Type
7.4.2 Russia Healthcare CRO Services Market by End User
7.4.3 Russia Healthcare CRO Services Market by Therapeutic Areas
7.5 Spain Healthcare CRO Services Market
7.5.1 Spain Healthcare CRO Services Market by Service Type
7.5.2 Spain Healthcare CRO Services Market by End User
7.5.3 Spain Healthcare CRO Services Market by Therapeutic Areas
7.6 Italy Healthcare CRO Services Market
7.6.1 Italy Healthcare CRO Services Market by Service Type
7.6.2 Italy Healthcare CRO Services Market by End User
7.6.3 Italy Healthcare CRO Services Market by Therapeutic Areas
7.7 Rest of Europe Healthcare CRO Services Market
7.7.1 Rest of Europe Healthcare CRO Services Market by Service Type
7.7.2 Rest of Europe Healthcare CRO Services Market by End User
7.7.3 Rest of Europe Healthcare CRO Services Market by Therapeutic Areas
CHAPTER 8. COMPANY PROFILES
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Healthcare CRO Services Market, by Service Type
1.4.2 Europe Healthcare CRO Services Market, by End User
1.4.3 Europe Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Europe Healthcare CRO Services Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Aug – 2020, Mar) Leading Players
CHAPTER 4. EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE
4.1 Europe Clinical Research Services Market by Country
4.2 Europe Early Phase Development Market by Country
4.3 Europe Laboratory Services Market by Country
4.4 Europe Consulting Services Market by Country
CHAPTER 5. EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER
5.1 Europe Pharmaceutical Sector Market by Country
5.2 Europe Medical Device Sector Market by Country
5.3 Europe Academic Institutes Market by Country
CHAPTER 6. EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS
6.1 Europe Oncology Market by Country
6.2 Europe CNS Disorder Market by Country
6.3 Europe Cardiovascular Disease Market by Country
6.4 Europe Diabetes Market by Country
6.5 Europe Metabolic Diseases Market by Country
6.6 Europe Infectious Diseases Market by Country
6.7 Europe Other therapeutic areas Market by Country
CHAPTER 7. EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY
7.1 Germany Healthcare CRO Services Market
7.1.1 Germany Healthcare CRO Services Market by Service Type
7.1.2 Germany Healthcare CRO Services Market by End User
7.1.3 Germany Healthcare CRO Services Market by Therapeutic Areas
7.2 UK Healthcare CRO Services Market
7.2.1 UK Healthcare CRO Services Market by Service Type
7.2.2 UK Healthcare CRO Services Market by End User
7.2.3 UK Healthcare CRO Services Market by Therapeutic Areas
7.3 France Healthcare CRO Services Market
7.3.1 France Healthcare CRO Services Market by Service Type
7.3.2 France Healthcare CRO Services Market by End User
7.3.3 France Healthcare CRO Services Market by Therapeutic Areas
7.4 Russia Healthcare CRO Services Market
7.4.1 Russia Healthcare CRO Services Market by Service Type
7.4.2 Russia Healthcare CRO Services Market by End User
7.4.3 Russia Healthcare CRO Services Market by Therapeutic Areas
7.5 Spain Healthcare CRO Services Market
7.5.1 Spain Healthcare CRO Services Market by Service Type
7.5.2 Spain Healthcare CRO Services Market by End User
7.5.3 Spain Healthcare CRO Services Market by Therapeutic Areas
7.6 Italy Healthcare CRO Services Market
7.6.1 Italy Healthcare CRO Services Market by Service Type
7.6.2 Italy Healthcare CRO Services Market by End User
7.6.3 Italy Healthcare CRO Services Market by Therapeutic Areas
7.7 Rest of Europe Healthcare CRO Services Market
7.7.1 Rest of Europe Healthcare CRO Services Market by Service Type
7.7.2 Rest of Europe Healthcare CRO Services Market by End User
7.7.3 Rest of Europe Healthcare CRO Services Market by Therapeutic Areas
CHAPTER 8. COMPANY PROFILES
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 EUROPE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– HEALTHCARE CRO SERVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– HEALTHCARE CRO SERVICES MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– HEALTHCARE CRO SERVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – HEALTHCARE CRO SERVICES MARKET
TABLE 7 EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 8 EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 9 EUROPE CLINICAL RESEARCH SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE CLINICAL RESEARCH SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE EARLY PHASE DEVELOPMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE EARLY PHASE DEVELOPMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE LABORATORY SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE LABORATORY SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE CONSULTING SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE CONSULTING SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 18 EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 19 EUROPE PHARMACEUTICAL SECTOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE PHARMACEUTICAL SECTOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE MEDICAL DEVICE SECTOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE MEDICAL DEVICE SECTOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 26 EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 27 EUROPE ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE CNS DISORDER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE CNS DISORDER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE CARDIOVASCULAR DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE CARDIOVASCULAR DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE METABOLIC DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE METABOLIC DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 EUROPE OTHER THERAPEUTIC AREAS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 EUROPE OTHER THERAPEUTIC AREAS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 GERMANY HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 44 GERMANY HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 45 GERMANY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 46 GERMANY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 47 GERMANY HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 48 GERMANY HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 49 GERMANY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 50 GERMANY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 51 UK HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 52 UK HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 53 UK HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 54 UK HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 55 UK HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 56 UK HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 57 UK HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 58 UK HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 59 FRANCE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 60 FRANCE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 61 FRANCE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 62 FRANCE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 63 FRANCE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 64 FRANCE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 65 FRANCE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 66 FRANCE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 69 RUSSIA HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 70 RUSSIA HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 71 RUSSIA HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 72 RUSSIA HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 73 RUSSIA HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 74 RUSSIA HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 75 SPAIN HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 76 SPAIN HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 77 SPAIN HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 78 SPAIN HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 79 SPAIN HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 80 SPAIN HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 81 SPAIN HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 82 SPAIN HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 83 ITALY HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 84 ITALY HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 85 ITALY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 86 ITALY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 87 ITALY HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 88 ITALY HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 89 ITALY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 90 ITALY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 93 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 94 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 95 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 96 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 97 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 98 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 99 KEY INFORMATION – IQVIA HOLDINGS, INC.
TABLE 100 KEY INFORMATION – LABORATORY CORPORATION OF AMERICA HOLDINGS
TABLE 101 KEY INFORMATION – PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
TABLE 102 KEY INFORMATION – PAREXEL INTERNATIONAL CORPORATION
TABLE 103 KEY INFORMATION – CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 104 KEY INFORMATION – ICON PLC
TABLE 105 KEY INFORMATION – DASSAULT SYSTEMES SE
TABLE 106 KEY INFORMATION – SYNEOS HEALTH, INC.
TABLE 107 KEY INFORMATION – PHARMARON BEIJING CO., LTD.
TABLE 108 KEY INFORMATION – GVK BIOSCIENCES PRIVATE LIMITED
TABLE 1 EUROPE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– HEALTHCARE CRO SERVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– HEALTHCARE CRO SERVICES MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– HEALTHCARE CRO SERVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – HEALTHCARE CRO SERVICES MARKET
TABLE 7 EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 8 EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 9 EUROPE CLINICAL RESEARCH SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE CLINICAL RESEARCH SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE EARLY PHASE DEVELOPMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE EARLY PHASE DEVELOPMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE LABORATORY SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE LABORATORY SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE CONSULTING SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE CONSULTING SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 18 EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 19 EUROPE PHARMACEUTICAL SECTOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE PHARMACEUTICAL SECTOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE MEDICAL DEVICE SECTOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE MEDICAL DEVICE SECTOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 26 EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 27 EUROPE ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE CNS DISORDER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE CNS DISORDER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE CARDIOVASCULAR DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE CARDIOVASCULAR DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 EUROPE METABOLIC DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE METABOLIC DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 EUROPE OTHER THERAPEUTIC AREAS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 EUROPE OTHER THERAPEUTIC AREAS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 EUROPE HEALTHCARE CRO SERVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 GERMANY HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 44 GERMANY HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 45 GERMANY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 46 GERMANY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 47 GERMANY HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 48 GERMANY HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 49 GERMANY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 50 GERMANY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 51 UK HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 52 UK HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 53 UK HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 54 UK HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 55 UK HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 56 UK HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 57 UK HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 58 UK HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 59 FRANCE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 60 FRANCE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 61 FRANCE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 62 FRANCE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 63 FRANCE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 64 FRANCE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 65 FRANCE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 66 FRANCE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 69 RUSSIA HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 70 RUSSIA HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 71 RUSSIA HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 72 RUSSIA HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 73 RUSSIA HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 74 RUSSIA HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 75 SPAIN HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 76 SPAIN HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 77 SPAIN HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 78 SPAIN HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 79 SPAIN HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 80 SPAIN HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 81 SPAIN HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 82 SPAIN HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 83 ITALY HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 84 ITALY HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 85 ITALY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 86 ITALY HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 87 ITALY HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 88 ITALY HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 89 ITALY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 90 ITALY HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET, 2019 - 2025, USD MILLION
TABLE 93 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2015 - 2018, USD MILLION
TABLE 94 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY SERVICE TYPE, 2019 - 2025, USD MILLION
TABLE 95 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 96 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 97 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2015 - 2018, USD MILLION
TABLE 98 REST OF EUROPE HEALTHCARE CRO SERVICES MARKET BY THERAPEUTIC AREAS, 2019 - 2025, USD MILLION
TABLE 99 KEY INFORMATION – IQVIA HOLDINGS, INC.
TABLE 100 KEY INFORMATION – LABORATORY CORPORATION OF AMERICA HOLDINGS
TABLE 101 KEY INFORMATION – PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
TABLE 102 KEY INFORMATION – PAREXEL INTERNATIONAL CORPORATION
TABLE 103 KEY INFORMATION – CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 104 KEY INFORMATION – ICON PLC
TABLE 105 KEY INFORMATION – DASSAULT SYSTEMES SE
TABLE 106 KEY INFORMATION – SYNEOS HEALTH, INC.
TABLE 107 KEY INFORMATION – PHARMARON BEIJING CO., LTD.
TABLE 108 KEY INFORMATION – GVK BIOSCIENCES PRIVATE LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, AUG – 2020, MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: LABORATORY CORPORATION OF AMERICA HOLDINGS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: PAREXEL INTERNATIONAL CORPORATION
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: ICON PLC
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: DASSAULT SYSTEMES SE
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, AUG – 2020, MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: LABORATORY CORPORATION OF AMERICA HOLDINGS
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: PAREXEL INTERNATIONAL CORPORATION
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: ICON PLC
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: DASSAULT SYSTEMES SE
